1st Circ. Strengthens Preemption For Brand-Name Drug Cos.
On Feb. 20, 2015, the First Circuit in In re: Celexa and Lexapro Marketing and Sales Practices Litigation affirmed the dismissal of plaintiffs' state law consumer protection claims against a brand-name...To view the full article, register now.
Already a subscriber? Click here to view full article